Loxo Oncology, Inc. 4
4 · Loxo Oncology, Inc. · Filed Jun 13, 2016
Insider Transaction Report
Form 4
Naider Avi Z.
Director
Transactions
- Award
Director Stock Option (right to buy)
2016-06-10+7,812→ 7,812 totalExercise: $24.18Exp: 2026-06-09→ Common Stock (7,812 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 12 equal monthly installments beginning one month after the grant date, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.